These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
205 related items for PubMed ID: 26124386
1. Association of Basal and Calcium-stimulated Calcitonin Levels with Pathological Findings After Total Thyroidectomy. Papadakis G, Keramidas I, Triantafillou E, Kanouta F, Pappa T, Kaltzidou V, Tertipi A, Iordanidou L, Trivizaki E, Vecchini G, Villiotou V, Pappas A. Anticancer Res; 2015 Jul; 35(7):4251-8. PubMed ID: 26124386 [Abstract] [Full Text] [Related]
2. Predictive value of pentagastrin test for preoperative differential diagnosis between C-cell hyperplasia and medullary thyroid carcinoma in patients with moderately elevated basal calcitonin levels. Milone F, Ramundo V, Chiofalo MG, Severino R, Paciolla I, Pezzullo L, Lombardi G, Colao A, Faggiano A. Clin Endocrinol (Oxf); 2010 Jul; 73(1):85-8. PubMed ID: 20039894 [Abstract] [Full Text] [Related]
3. Can sporadic medullary thyroid carcinoma be biochemically predicted? Prospective analysis of 66 operated patients with elevated serum calcitonin levels. Iacobone M, Niccoli-Sire P, Sebag F, De Micco C, Henry JF. World J Surg; 2002 Aug; 26(8):886-90. PubMed ID: 12016469 [Abstract] [Full Text] [Related]
4. Refining calcium test for the diagnosis of medullary thyroid cancer: cutoffs, procedures, and safety. Mian C, Perrino M, Colombo C, Cavedon E, Pennelli G, Ferrero S, De Leo S, Sarais C, Cacciatore C, Manfredi GI, Verga U, Iacobone M, De Pasquale L, Pelizzo MR, Vicentini L, Persani L, Fugazzola L. J Clin Endocrinol Metab; 2014 May; 99(5):1656-64. PubMed ID: 24552221 [Abstract] [Full Text] [Related]
5. Calcium-stimulated calcitonin - The "new standard" in the diagnosis of thyroid C-cell disease - clinically relevant gender-specific cut-off levels for an "old test". Niederle MB, Scheuba C, Gessl A, Li S, Koperek O, Bieglmayer C, Riss P, Selberherr A, Niederle B. Biochem Med (Zagreb); 2018 Oct 15; 28(3):030710. PubMed ID: 30429678 [Abstract] [Full Text] [Related]
6. Calcitonin concentrations in patients with chronic kidney disease and medullary thyroid carcinoma or c-cell hyperplasia. Borchhardt KA, Heinzl H, Gessl A, Hörl WH, Kaserer K, Sunder-Plassmann G. Kidney Int; 2006 Dec 15; 70(11):2014-20. PubMed ID: 17051143 [Abstract] [Full Text] [Related]
7. Predictive value of serum calcitonin levels for preoperative diagnosis of medullary thyroid carcinoma in a cohort of 5817 consecutive patients with thyroid nodules. Costante G, Meringolo D, Durante C, Bianchi D, Nocera M, Tumino S, Crocetti U, Attard M, Maranghi M, Torlontano M, Filetti S. J Clin Endocrinol Metab; 2007 Feb 15; 92(2):450-5. PubMed ID: 17119000 [Abstract] [Full Text] [Related]
8. Is medullary thyroid cancer predictable? A prospective study of 86 patients with abnormal pentagastrin tests. Scheuba C, Kaserer K, Weinhäusl A, Pandev R, Kaider A, Passler C, Prager G, Vierhapper H, Haas OA, Niederle B. Surgery; 1999 Dec 15; 126(6):1089-95; discussion 1096. PubMed ID: 10598192 [Abstract] [Full Text] [Related]
9. Reference values of serum calcitonin with calcium stimulation tests by electrochemiluminescence immunoassay before/after total thyroidectomy in Japanese patients with thyroid diseases other than medullary thyroid carcinoma. Kihara M, Miyauchi A, Kudo T, Hirokawa M, Miya A. Endocr J; 2016 Jul 30; 63(7):627-32. PubMed ID: 27097651 [Abstract] [Full Text] [Related]
11. Comparison of calcium and pentagastrin tests for the diagnosis and follow-up of medullary thyroid cancer. Colombo C, Verga U, Mian C, Ferrero S, Perrino M, Vicentini L, Dazzi D, Opocher G, Pelizzo MR, Beck-Peccoz P, Fugazzola L. J Clin Endocrinol Metab; 2012 Mar 30; 97(3):905-13. PubMed ID: 22170709 [Abstract] [Full Text] [Related]
12. New mutations in the RET protooncogene-L881V - associated with medullary thyroid carcinoma and -R770Q - in a patient with mixed medullar/follicular thyroid tumour. Frank-Raue K, Döhring J, Scheumann G, Rondot S, Lorenz A, Schulze E, Dralle H, Raue F, Leidig-Bruckner G. Exp Clin Endocrinol Diabetes; 2010 Aug 30; 118(8):550-3. PubMed ID: 20013610 [Abstract] [Full Text] [Related]
13. Predictive Value of Calcium Test for Preoperative Diagnosis of Medullary Thyroid Carcinoma in Patients With Moderately Elevated Basal Calcitonin. Tausanovic KM, Zivaljevic VR, Zorić GV, Jovanovic MD, Stepanovic BG, Milenkovic MG, Paunovic IR. Endocr Pract; 2021 Nov 30; 27(11):1077-1081. PubMed ID: 34216799 [Abstract] [Full Text] [Related]
14. Sporadic hypercalcitoninemia: clinical and therapeutic consequences. Scheuba C, Kaserer K, Moritz A, Drosten R, Vierhapper H, Bieglmayer C, Haas OA, Niederle B. Endocr Relat Cancer; 2009 Mar 30; 16(1):243-53. PubMed ID: 18987170 [Abstract] [Full Text] [Related]
15. Serum calcitonin levels with calcium loading tests before and after total thyroidectomy in patients with thyroid diseases other than medullary thyroid carcinoma. Kudo T, Miyauchi A, Ito Y, Yabuta T, Inoue H, Higashiyama T, Tomoda C, Hirokawa M, Amino N. Endocr J; 2011 Mar 30; 58(3):217-21. PubMed ID: 21358115 [Abstract] [Full Text] [Related]
16. Efficacy of procalcitonin measurement in patients after total thyroidectomy due to medullary thyroid carcinoma. Bolko P, Manuszewska-Jopek E, Michałek K, Waśko R, Jaskuła M, Sowiński J. Arch Immunol Ther Exp (Warsz); 2003 Mar 30; 51(6):415-9. PubMed ID: 14692663 [Abstract] [Full Text] [Related]
20. Medullary thyroid carcinoma: results of a standardized surgical approach in a contemporary series of 80 consecutive patients. Yen TW, Shapiro SE, Gagel RF, Sherman SI, Lee JE, Evans DB. Surgery; 2003 Dec 30; 134(6):890-9; discussion 899-901. PubMed ID: 14668720 [Abstract] [Full Text] [Related] Page: [Next] [New Search]